HER2 positive carcinoma of the breast is an aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2…
HER2 positive biliary tract malignancy is a rare but aggressive form of cancer that affects the bile ducts, gallbladder, and ampulla of Vater. Understanding its…
HER2-positive adenocarcinoma of the gastroesophageal junction (GEJ) is a rare yet aggressive malignancy that requires targeted treatment strategies. This condition is characterized by the overexpression…
HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma is a challenging form of cancer with distinct characteristics that require specialized treatment approaches. Understanding its pathology, diagnosis,…
Gastric and gastroesophageal junction (GEJ) adenocarcinomas are aggressive malignancies with limited treatment options. Recent advancements have identified CLDN18.2 as a promising biomarker in patients with…
Human Epidermal Growth Factor Receptor 2 (HER2) mutant non-small cell lung cancer (NSCLC) is a rare but significant subtype of lung cancer characterized by specific…
Hepatorenal syndrome (HRS) is a severe complication of advanced liver disease characterized by functional kidney failure. This condition is commonly associated with cirrhosis, acute liver…
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). The most effective preventive measure against this disease is vaccination. The…
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). As a global health concern, it requires comprehensive preventive strategies to…
Hepatitis A is a contagious liver infection caused by the hepatitis A virus (HAV). It is commonly transmitted through contaminated food, water, or close contact…